Advanced search
Publication Cover
Cancer Investigation Volume 36, 2018 - Issue 4
Submit an article Journal homepage
279
Views
21
CrossRef citations to date
0
Altmetric
Articles

Outcomes of Surgery as Part of the Management of Metastatic Non–Small-Cell Lung Cancer: A Surveillance, Epidemiology and End Results Database Analysis

Omar Abdel-RahmanClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, EgyptCorrespondence[email protected]
Pages 238-245 | Received 05 Jan 2017, Accepted 30 Mar 2018, Published online: 18 May 2018

References

  • http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Last accessed Accessed at 3/8/2016
  • Paleiron N, Bylicki O, André M, Rivière E, Grassin F, Robinet G, Chouaïd C. Targeted therapy for localized non-small-cell lung cancer: a review. Onco Targets Ther. 2016;9:4099–4104. doi:10.2147/OTT.S104938. PMID:27462164.
  • Abdel-Rahman O. Hepatocellular carcinoma (HCC); aetiological considerations. Adv Mod Oncol Res. 2015;1(1):1–3.
  • Sen F, Tambas M, Ozkaya K, Guveli ME, Ciftci R, Ozkan B, Oral EN, Saglam EK, Saip P, Toker A, et al. Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy. Medicine. 2016;95(30):e4280. doi:10.1097/MD.0000000000004280. PMID:27472701.
  • Aggarwal C. Targeted therapy for lung cancer: present and future. Annals of palliative medicine. 2014;3(3):229–235. PMID:25841697.
  • Bansal P, Rusthoven C, Boumber Y, Gan GN. The role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope. Future Oncol. 2016;12(23):2713–2727. PMID:27467543.
  • Surveillance, Epidemiology and End Results Program. About the SEER Program. Available at: http://seer.cancer.gov/about. Accessed Accessed at June 25, 2016.
  • Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55. doi:10.1093/biomet/70.1.41.
  • Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods That incorporate the propensity score. Am Stat. 1985;39(1):33–38.
  • Austin PC. An Introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424. doi:10.1080/00273171.2011.568786. PMID:21818162.
  • Davis KL, Goyal RK, Able SL, Brown J, Li L, Kaye JA. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer. Lung Cancer. 87(2):176–185. doi:10.1016/j.lungcan.2014.11.002. PMID:25532680.
  • Goncalves PH, Peterson SL, Vigneau FD, Shore RD, Quarshie WO, Islam K, Schwartz AG, Wozniak AJ, Gadgeel SM. Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data. Cancer. 2016;122(12):1921–1927. doi:10.1002/cncr.30000. PMID:27062154.
  • Ren Y, Dai C, Zheng H, Zhou F, She Y, Jiang G, et al. Prognostic effect of liver metastasis in lung cancer patients with distant metastasis. Oncotarget. 2016;7:53245–53253.
  • Benson AB, Venook AP, Bekaii-Saab T, Chan E, Chen Y-J, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, et al. Colon cancer, version 3.2014. J Natl Compr Canc Netw. 2014;12(7):1028–1059. doi:10.6004/jnccn.2014.0099. PMID:24994923.
  • Fujitani K, Yang H-K, Mizusawa J, Kim Y-W, Terashima M, Han S-U, Iwasaki Y, Hyung WJ, Takagane A, Park DJ, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17(3):309–318. doi:10.1016/S1470-2045(15)00553-7. PMID:26822397.
  • Ren Y, Dai C, Shen J, Liu Y, Xie D, Zheng H, He J, Liang W, Jiang G, Fei K, et al. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected. Oncotarget. 2016;7(18):26856–26865. doi:10.18632/oncotarget.8566.
  • Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39–51. doi:10.1016/j.jtho.2015.09.009. PMID:26762738.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.